Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:375427.
doi: 10.1155/2015/375427. Epub 2015 May 18.

A Single Nucleotide Polymorphism (rs4236480) in TRPV5 Calcium Channel Gene Is Associated with Stone Multiplicity in Calcium Nephrolithiasis Patients

Affiliations

A Single Nucleotide Polymorphism (rs4236480) in TRPV5 Calcium Channel Gene Is Associated with Stone Multiplicity in Calcium Nephrolithiasis Patients

Anas Khaleel et al. Mediators Inflamm. 2015.

Abstract

Nephrolithiasis is characterized by calcification of stones in the kidneys from an unknown cause. Animal models demonstrated the functional roles of the transient receptor potential vanilloid member 5 (TRPV5) gene in calcium renal reabsorption and hypercalciuria. Therefore, TRPV5 was suggested to be involved in calcium homeostasis. However, whether genetic polymorphisms of TRPV5 are associated with kidney stone multiplicity or recurrence is unclear. In this study, 365 Taiwanese kidney-stone patients were recruited. Both biochemical data and DNA samples were collected. Genotyping was performed by a TaqMan allelic discrimination assay. We found that a TRPV5 polymorphism (rs4236480) was observed to be associated with stone multiplicity of calcium nephrolithiasis, as the risk of stone multiplicity was higher in patients with the TT+CT genotype than in patients with the CC genotype (p = 0.0271). In summary, despite the complexity of nephrolithiasis and the potential association of numerous calcium homeostatic absorption/reabsorption factors, TRPV5 plays an important role in the pathogenesis of calcium nephrolithiasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graphical overview of the genotyped human TRPV5 gene.

References

    1. Moe O. W. Kidney stones: pathophysiology and medical management. The Lancet. 2006;367(9507):333–344. doi: 10.1016/s0140-6736(06)68071-9. - DOI - PubMed
    1. Romero V., Akpinar H., Assimos D. G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Reviews in Urology. 2010;12(2-3):e86–e96. - PMC - PubMed
    1. Atan L., Andreoni C., Ortiz V., et al. High kidney stone risk in men working in steel industry at hot temperatures. Urology. 2005;65(5):858–861. doi: 10.1016/j.urology.2004.11.048. - DOI - PubMed
    1. Bihl G., Meyers A. Recurrent renal stone disease—advances in pathogenesis and clinical management. Lancet. 2001;358(9282):651–656. doi: 10.1016/s0140-6736(01)05782-8. - DOI - PubMed
    1. Goldfarb D. S. Prospects for dietary therapy of recurrent nephrolithiasis. Advances in Chronic Kidney Disease. 2009;16(1):21–29. doi: 10.1053/j.ackd.2008.10.010. - DOI - PubMed

Publication types

LinkOut - more resources